Oncolytics Biotech, Inc.(Toronto Stock Exchange : ONCY)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 0.07% | 67.61 | 1.0% | $1048.91m | |
| BIIB | Biogen, Inc. | 2.70% | 342.00 | 1.5% | $718.24m | |
| AMGN | Amgen, Inc. | -0.62% | 222.09 | 1.3% | $585.61m | |
| ILMN | Illumina, Inc. | 2.59% | 298.92 | 3.5% | $440.19m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.45% | 397.74 | 2.6% | $385.35m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.74% | 242.01 | 1.9% | $346.26m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.00% | 102.56 | 2.0% | $208.61m | |
| EXAS | EXACT Sciences Corp. | 3.61% | 98.18 | 24.0% | $165.42m | |
| A | Agilent Technologies, Inc. | 0.20% | 86.01 | 1.6% | $151.72m | |
| SGEN | Seattle Genetics, Inc. | -0.13% | 118.07 | 6.1% | $116.25m | |
| MRNA | Moderna, Inc. | -0.05% | 18.99 | 0.0% | $111.22m | |
| INCY | Incyte Corp. | -0.57% | 78.00 | 2.5% | $100.64m | |
| XLRN | Acceleron Pharma, Inc. | -0.48% | 93.66 | 6.1% | $99.78m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.31% | 125.42 | 14.6% | $97.24m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.87% | 89.01 | 4.3% | $93.97m |
Company Profile
Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.